SDTM001 Injection

SDTM001 · Cytocraft Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SDTM001 Injection, covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection [Phase 1]